πŸ‡ΊπŸ‡Έ FDA
Patent

US 9617229

Phenylmorpholines and analogues thereof

granted A61PA61P15/00A61P15/10

Quick answer

US patent 9617229 (Phenylmorpholines and analogues thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P15/00, A61P15/10, A61P25/04, A61P25/06